Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase

Kyung D. Moon, Carol B. Post, Donald L. Durden, Qing Zhou, Pradip De, Marietta L. Harrison, Robert L. Geahlen

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

After engagement of the B cell receptor for antigen, the Syk protein-tyrosine kinase becomes phosphorylated on multiple tyrosines, some of which serve as docking sites for downstream effectors with SH2 or other phosphotyrosine binding domains. The most frequently identified binding partner for catalytically active Syk identified in a yeast two-hybrid screen was the p85 regulatory subunit of phosphoinositide 3-kinase. The C-terminal SH2 domain of p85 was sufficient for mediating an interaction with tyrosine-phosphorylated Syk. Interestingly, this domain interacted with Syk at phosphotyrosine 317, a site phosphorylated in trans by the Src family kinase, Lyn, and identified previously as a binding site for c-Cbl. This site interacted preferentially with the p85 C-terminal SH2 domain compared with the c-Cbl tyrosine kinase binding domain. Molecular modeling studies showed a good fit between the p85 SH2 domain and a peptide containing phosphotyrosine 317. Tyr-317 was found to be essential for Syk to support phagocytosis mediated by FcγRIIA receptors expressed in a heterologous system. These studies establish a new type of p85 binding site that can exist on proteins that serve as substrates for Src family kinases and provide a molecular explanation for observations on direct interactions between Syk and phosphoinositide 3-kinase.

Original languageEnglish (US)
Pages (from-to)1543-1551
Number of pages9
JournalJournal of Biological Chemistry
Volume280
Issue number2
DOIs
StatePublished - Jan 14 2005

Fingerprint

Phosphotyrosine
1-Phosphatidylinositol 4-Kinase
src Homology Domains
Phosphatidylinositols
Protein-Tyrosine Kinases
Phosphotransferases
src-Family Kinases
Tyrosine
Binding Sites
B-Cell Antigen Receptors
Molecular modeling
Phagocytosis
Yeast
Yeasts
Peptides
Substrates
Syk Kinase
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Moon, K. D., Post, C. B., Durden, D. L., Zhou, Q., De, P., Harrison, M. L., & Geahlen, R. L. (2005). Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase. Journal of Biological Chemistry, 280(2), 1543-1551. https://doi.org/10.1074/jbc.M407805200

Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase. / Moon, Kyung D.; Post, Carol B.; Durden, Donald L.; Zhou, Qing; De, Pradip; Harrison, Marietta L.; Geahlen, Robert L.

In: Journal of Biological Chemistry, Vol. 280, No. 2, 14.01.2005, p. 1543-1551.

Research output: Contribution to journalArticle

Moon, Kyung D. ; Post, Carol B. ; Durden, Donald L. ; Zhou, Qing ; De, Pradip ; Harrison, Marietta L. ; Geahlen, Robert L. / Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase. In: Journal of Biological Chemistry. 2005 ; Vol. 280, No. 2. pp. 1543-1551.
@article{3e813ce0448640b3a2adc03e1bde3636,
title = "Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase",
abstract = "After engagement of the B cell receptor for antigen, the Syk protein-tyrosine kinase becomes phosphorylated on multiple tyrosines, some of which serve as docking sites for downstream effectors with SH2 or other phosphotyrosine binding domains. The most frequently identified binding partner for catalytically active Syk identified in a yeast two-hybrid screen was the p85 regulatory subunit of phosphoinositide 3-kinase. The C-terminal SH2 domain of p85 was sufficient for mediating an interaction with tyrosine-phosphorylated Syk. Interestingly, this domain interacted with Syk at phosphotyrosine 317, a site phosphorylated in trans by the Src family kinase, Lyn, and identified previously as a binding site for c-Cbl. This site interacted preferentially with the p85 C-terminal SH2 domain compared with the c-Cbl tyrosine kinase binding domain. Molecular modeling studies showed a good fit between the p85 SH2 domain and a peptide containing phosphotyrosine 317. Tyr-317 was found to be essential for Syk to support phagocytosis mediated by FcγRIIA receptors expressed in a heterologous system. These studies establish a new type of p85 binding site that can exist on proteins that serve as substrates for Src family kinases and provide a molecular explanation for observations on direct interactions between Syk and phosphoinositide 3-kinase.",
author = "Moon, {Kyung D.} and Post, {Carol B.} and Durden, {Donald L.} and Qing Zhou and Pradip De and Harrison, {Marietta L.} and Geahlen, {Robert L.}",
year = "2005",
month = "1",
day = "14",
doi = "10.1074/jbc.M407805200",
language = "English (US)",
volume = "280",
pages = "1543--1551",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "2",

}

TY - JOUR

T1 - Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase

AU - Moon, Kyung D.

AU - Post, Carol B.

AU - Durden, Donald L.

AU - Zhou, Qing

AU - De, Pradip

AU - Harrison, Marietta L.

AU - Geahlen, Robert L.

PY - 2005/1/14

Y1 - 2005/1/14

N2 - After engagement of the B cell receptor for antigen, the Syk protein-tyrosine kinase becomes phosphorylated on multiple tyrosines, some of which serve as docking sites for downstream effectors with SH2 or other phosphotyrosine binding domains. The most frequently identified binding partner for catalytically active Syk identified in a yeast two-hybrid screen was the p85 regulatory subunit of phosphoinositide 3-kinase. The C-terminal SH2 domain of p85 was sufficient for mediating an interaction with tyrosine-phosphorylated Syk. Interestingly, this domain interacted with Syk at phosphotyrosine 317, a site phosphorylated in trans by the Src family kinase, Lyn, and identified previously as a binding site for c-Cbl. This site interacted preferentially with the p85 C-terminal SH2 domain compared with the c-Cbl tyrosine kinase binding domain. Molecular modeling studies showed a good fit between the p85 SH2 domain and a peptide containing phosphotyrosine 317. Tyr-317 was found to be essential for Syk to support phagocytosis mediated by FcγRIIA receptors expressed in a heterologous system. These studies establish a new type of p85 binding site that can exist on proteins that serve as substrates for Src family kinases and provide a molecular explanation for observations on direct interactions between Syk and phosphoinositide 3-kinase.

AB - After engagement of the B cell receptor for antigen, the Syk protein-tyrosine kinase becomes phosphorylated on multiple tyrosines, some of which serve as docking sites for downstream effectors with SH2 or other phosphotyrosine binding domains. The most frequently identified binding partner for catalytically active Syk identified in a yeast two-hybrid screen was the p85 regulatory subunit of phosphoinositide 3-kinase. The C-terminal SH2 domain of p85 was sufficient for mediating an interaction with tyrosine-phosphorylated Syk. Interestingly, this domain interacted with Syk at phosphotyrosine 317, a site phosphorylated in trans by the Src family kinase, Lyn, and identified previously as a binding site for c-Cbl. This site interacted preferentially with the p85 C-terminal SH2 domain compared with the c-Cbl tyrosine kinase binding domain. Molecular modeling studies showed a good fit between the p85 SH2 domain and a peptide containing phosphotyrosine 317. Tyr-317 was found to be essential for Syk to support phagocytosis mediated by FcγRIIA receptors expressed in a heterologous system. These studies establish a new type of p85 binding site that can exist on proteins that serve as substrates for Src family kinases and provide a molecular explanation for observations on direct interactions between Syk and phosphoinositide 3-kinase.

UR - http://www.scopus.com/inward/record.url?scp=12544249891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12544249891&partnerID=8YFLogxK

U2 - 10.1074/jbc.M407805200

DO - 10.1074/jbc.M407805200

M3 - Article

C2 - 15536084

AN - SCOPUS:12544249891

VL - 280

SP - 1543

EP - 1551

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 2

ER -